tiprankstipranks
Fuji Pharma Co., Ltd. (DE:FUP)
FRANKFURT:FUP
Germany Market
FUP
Fuji Pharma Co., Ltd.
RESEARCH TOOLSreports

Fuji Pharma Co., Ltd. (FUP) Ratios

0 Followers

Fuji Pharma Co., Ltd. Ratios

DE:FUP's free cash flow for Q3 2026 was ¥0.34. For the 2026 fiscal year, DE:FUP's free cash flow was decreased by ¥ and operating cash flow was ¥0.06. See a summary of the company’s cash flow.
Ratios
TTM
Sep 25Sep 24Sep 23Sep 22
Liquidity Ratios
Current Ratio
 1.66 1.55 1.19 1.31 1.45
Quick Ratio
 0.95 0.86 0.68 0.66 0.79
Cash Ratio
 0.30 0.23 0.13 0.08 0.15
Solvency Ratio
 0.15 0.15 0.22 0.15 0.14
Operating Cash Flow Ratio
 0.18 0.19 0.12 0.06 -0.03
Short-Term Operating Cash Flow Coverage
 0.33 0.34 0.19 0.12 -0.06
Net Current Asset Value
¥ 8.15B¥ 1.20B¥ -2.54B¥ -5.04B¥ -5.01B
Leverage Ratios
Debt-to-Assets Ratio
 0.29 0.33 0.32 0.34 0.33
Debt-to-Equity Ratio
 0.56 0.66 0.64 0.70 0.69
Debt-to-Capital Ratio
 0.36 0.40 0.39 0.41 0.41
Long-Term Debt-to-Capital Ratio
 0.13 0.16 0.03 0.17 0.24
Financial Leverage Ratio
 1.90 2.00 1.99 2.07 2.11
Debt Service Coverage Ratio
 0.59 0.45 0.24 0.40 0.51
Interest Coverage Ratio
 18.47 15.12 19.80 31.88 49.05
Debt to Market Cap
 0.52 0.70 0.77 0.89 0.87
Interest Debt Per Share
 1.12K 1.28K 1.21K 1.20K 1.01K
Net Debt to EBITDA
 1.70 2.65 3.26 3.53 3.22
Profitability Margins
Gross Profit Margin
39.39%37.33%35.79%40.39%41.10%
EBIT Margin
11.67%9.66%8.41%11.02%10.66%
EBITDA Margin
18.53%17.33%16.39%18.45%18.41%
Operating Profit Margin
11.67%9.66%8.41%9.44%10.66%
Pretax Profit Margin
5.68%7.74%17.94%10.76%10.51%
Net Profit Margin
4.97%5.81%13.32%8.40%7.61%
Continuous Operations Profit Margin
4.97%5.81%13.33%8.40%7.61%
Net Income Per EBT
87.63%75.00%74.28%78.09%72.41%
EBT Per EBIT
48.62%80.16%213.24%114.02%98.57%
Return on Assets (ROA)
3.04%3.20%6.79%4.03%3.57%
Return on Equity (ROE)
6.04%6.40%13.49%8.34%7.53%
Return on Capital Employed (ROCE)
10.72%7.97%7.08%6.94%7.33%
Return on Invested Capital (ROIC)
7.39%4.65%3.71%4.15%4.37%
Return on Tangible Assets
3.52%3.76%7.87%4.59%4.14%
Earnings Yield
6.16%7.95%19.86%12.12%10.73%
Efficiency Ratios
Receivables Turnover
 3.02 2.83 2.44 2.48 2.80
Payables Turnover
 6.33 7.09 7.16 4.30 3.34
Inventory Turnover
 1.56 1.53 1.65 1.26 1.32
Fixed Asset Turnover
 2.88 2.47 2.21 1.99 1.89
Asset Turnover
 0.61 0.55 0.51 0.48 0.47
Working Capital Turnover Ratio
 2.75 4.38 5.76 4.07 2.79
Cash Conversion Cycle
 297.03 316.73 320.18 352.61 297.91
Days of Sales Outstanding
 120.70 129.13 149.35 147.47 130.45
Days of Inventory Outstanding
 234.04 239.10 221.83 290.08 276.77
Days of Payables Outstanding
 57.71 51.51 51.01 84.94 109.31
Operating Cycle
 354.74 368.23 371.19 437.55 407.22
Cash Flow Ratios
Operating Cash Flow Per Share
 222.09 237.72 170.75 78.88 -27.09
Free Cash Flow Per Share
 146.25 156.54 56.48 -81.48 -538.46
CapEx Per Share
 75.84 81.18 114.27 160.36 511.38
Free Cash Flow to Operating Cash Flow
 0.66 0.66 0.33 -1.03 19.88
Dividend Paid and CapEx Coverage Ratio
 1.92 1.92 1.11 0.40 -0.05
Capital Expenditure Coverage Ratio
 2.93 2.93 1.49 0.49 -0.05
Operating Cash Flow Coverage Ratio
 0.20 0.19 0.14 0.07 -0.03
Operating Cash Flow to Sales Ratio
 0.10 0.11 0.09 0.05 -0.02
Free Cash Flow Yield
7.87%10.13%4.44%-6.99%-52.08%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 15.65 12.58 5.03 8.25 9.32
Price-to-Sales (P/S) Ratio
 0.81 0.73 0.67 0.69 0.71
Price-to-Book (P/B) Ratio
 0.94 0.80 0.68 0.69 0.70
Price-to-Free Cash Flow (P/FCF) Ratio
 12.73 9.88 22.54 -14.31 -1.92
Price-to-Operating Cash Flow Ratio
 8.38 6.50 7.46 14.78 -38.17
Price-to-Earnings Growth (PEG) Ratio
 -2.83 -0.24 0.06 0.30 0.41
Price-to-Fair Value
 0.94 0.80 0.68 0.69 0.70
Enterprise Value Multiple
 6.07 6.86 7.36 7.29 7.07
Enterprise Value
 67.50B 61.42B 55.62B 54.96B 46.14B
EV to EBITDA
 6.06 6.86 7.36 7.29 7.07
EV to Sales
 1.12 1.19 1.21 1.34 1.30
EV to Free Cash Flow
 17.67 16.08 40.51 -27.76 -3.53
EV to Operating Cash Flow
 11.64 10.59 13.40 28.67 -70.12
Tangible Book Value Per Share
 1.47K 1.35K 1.36K 1.26K 1.05K
Shareholders’ Equity Per Share
 1.99K 1.92K 1.87K 1.69K 1.47K
Tax and Other Ratios
Effective Tax Rate
 0.12 0.25 0.26 0.22 0.28
Revenue Per Share
 2.30K 2.12K 1.90K 1.68K 1.46K
Net Income Per Share
 114.47 122.94 252.85 141.35 110.98
Tax Burden
 0.88 0.75 0.74 0.78 0.72
Interest Burden
 0.49 0.80 2.13 0.98 0.99
Research & Development to Revenue
 0.06 0.06 0.07 0.08 0.07
SG&A to Revenue
 0.22 0.21 0.20 0.00 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 1.94 1.93 0.68 0.44 -0.18
Currency in JPY